Small molecule biomarkers for neonatal hypoxic ischemic encephalopathy
Hypoxic Ischemic Encephalopathy (HIE) is one of the most deleterious conditions in the perinatal period and the access to small molecule biomarkers aiding accurate diagnosis and disease staging, progress monitoring, and early outcome prognosis could provide relevant advances towards the development of personalized therapies. The emergence of metabolomics, the “omics” technology enabling the holistic study of small molecules, for biomarker discovery employing different analytical platforms, animal models and study populations has drastically increased the number and diversity of small molecules proposed as candidate biomarkers.
Source: Seminars in Fetal and Neonatal Medicine - Category: Perinatology & Neonatology Authors: Ángel Sánchez-Illana, José David Piñeiro-Ramos, Julia Kuligowski Source Type: research
More News: Perinatology & Neonatology | Study